We have developed OMICtools, a freely workflow for genomic, transcriptomic, proteomic, and metabolomic data analysis. All tools (programs and databases) have been classified by omic technologies (NGS, microarray, PCR, MS, NMR). Schematic workflows with clickable regions are provided for each omic application to guide newcomers.
OMICtools is expected to serve as a useful didactic resource not only for bioinformaticians, but also for experimental researchers and clinicians. An interface has been established to allow anyone to report a problem, write a comment or rate a given website, in an attempt to develop an interactive community.
One year after online kickoff, OMICtools has 1000 daily users from around the world (34% EU, 33% USA and 30% Asia).
In collaboration with the Neuroscience Information Framework (NIF), OMICtools has added a unique Research Resource Identifiers (RRIDs) for each software tool and database (See the Resource Identification Portal).
As a next step in OMICtools content development, we are assembling teams of volunteer curators to review and categorize programs, databases and links to literature, for each specialized field. The amount of time volunteer curators spend on the project is entirely user-guided.
Twenty volunteer curators recently joined us.
The aim of OMICtools is to build a consortium of users who share our desire to provide the scientific community with an educational and full-quality tool related to bioinformatics.
Participants will be associated in the next publication.
We are at your disposal should you require further information.
Thank you for your time and interest. Any comments and feedback are most welcome.
Best regards,
Arnaud
Arnaud Desfeux
OMICtools coordinator
+33675493544
OK, but what exactly is the business model for STATSARRAY LLC
it is on their website: http://statsarray.com/
Dear Christopher,
The business model of STATSARRAY (website) will not work for me. Competition is to large (see Geoff's Bio-Directories) and I didn't have enough money to have an immediate impact. Furthermore, big pharma have their own team and academic laboratories prefer to do the work themselves.
I have preferred to focus in the development of OMICsearch and OMICtools.
My business plan is moving :) I would like to develop a business around these free services.
Best
Arnaud